Efficacy News and Research

RSS
Reviva Pharmaceuticals completes enrollment in RP5063 phase 2 trial for schizophrenia

Reviva Pharmaceuticals completes enrollment in RP5063 phase 2 trial for schizophrenia

Pfizer’s Quillivant XR now available in the U.S. for treatment of ADHD

Pfizer’s Quillivant XR now available in the U.S. for treatment of ADHD

Tailored asthma therapy on the horizon

Tailored asthma therapy on the horizon

Pill color switch disrupts medication adherence

Pill color switch disrupts medication adherence

Bionic devices: an interview with Dr Rylie Green

Bionic devices: an interview with Dr Rylie Green

Additional insights into workings of ALVAC vaccine against HIV

Additional insights into workings of ALVAC vaccine against HIV

Cholera could be contained in Haiti by vaccinating less than half the population

Cholera could be contained in Haiti by vaccinating less than half the population

Viewpoints: Rove says GOP unlikely to make much 'structural change' to entitlements; Roe anniversary and fading public understanding; Fast food workers' health insurance

Viewpoints: Rove says GOP unlikely to make much 'structural change' to entitlements; Roe anniversary and fading public understanding; Fast food workers' health insurance

Parkinson’s assessment devices from Great Lakes NeuroTechnologies receive TGA approval

Parkinson’s assessment devices from Great Lakes NeuroTechnologies receive TGA approval

Patients at high-risk for recurrent C. difficile with unnecessary antibiotic use

Patients at high-risk for recurrent C. difficile with unnecessary antibiotic use

Fingolimod could potentially eliminate or reduce progression of colitis-associated cancer

Fingolimod could potentially eliminate or reduce progression of colitis-associated cancer

Concern regarding cefixime failure rate in gonorrhea patients

Concern regarding cefixime failure rate in gonorrhea patients

CTI initiates enrollment in pacritinib Phase 3 trial for myelofibrosis

CTI initiates enrollment in pacritinib Phase 3 trial for myelofibrosis

Lilly, Boehringer Ingelheim announce top-line results from empagliflozin Phase III trials on T2D

Lilly, Boehringer Ingelheim announce top-line results from empagliflozin Phase III trials on T2D

Oramed files IND with FDA to begin ORMD-0801 Phase 2 trial for type 2 diabetes

Oramed files IND with FDA to begin ORMD-0801 Phase 2 trial for type 2 diabetes

Psychologic treatment has long-term benefits for bipolar patients

Psychologic treatment has long-term benefits for bipolar patients

Contingency management benefits drug-dependent mental health patients

Contingency management benefits drug-dependent mental health patients

Adolescents may lose hepatitis B virus protection despite vaccination as infants

Adolescents may lose hepatitis B virus protection despite vaccination as infants

Esperion reports positive results from ETC-1002 Phase 2 clinical trial on type 2 diabetes

Esperion reports positive results from ETC-1002 Phase 2 clinical trial on type 2 diabetes

Thoratec to start REVIVE-IT study using HeartMate II Left Ventricular Assist System

Thoratec to start REVIVE-IT study using HeartMate II Left Ventricular Assist System

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.